Year of approval | Cancer stage | Agent | Study name | Chemotherapy |
---|---|---|---|---|
1998 [2] | First-line metastatic | T | - | Pac or AC |
1998 [2] | Second-line and third-line metastatic | T | - | None |
Adjuvant | T | B31/N9831/BCIG006 | AC → Pac, TCH | |
2006 [16] | Metastatic | L | - | Capecitabine |
2009 [17] | Metastatic | L + AI | TAnDEM | None |
2012 [18] | Metastatic | P + T | CLEOPATRA | Docetaxel |
2013 [13] | Metastatic | TDM-1 | EMILIA | None |
2013 [19] | Neoadjuvant | P + T | NeoSphere | FEC → Pac, TCH |